Skip to main content
logo
ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4661
+0.0446 (10.57%)
At close: Jul 25, 2025, 4:00 PM
0.4699
+0.0038 (0.83%)
After-hours: Jul 25, 2025, 7:59 PM EDT

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $19.36 million as of July 25, 2025. Its market cap has decreased by -70.75% in one year.

Market Cap
19.36M
Enterprise Value
33.28M
1-Year Change
-70.75%
Ranking
#4967
Category
Nano-Cap
Stock Price
$0.47

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $19.36M, a decrease of -78.96%. That is a compound annual growth rate of -5.68%.

History

DateMarket Cap% Change
Jul 25, 202519.40M7.18%
Dec 31, 202418.10M-77.82%
Dec 29, 202381.60M-47.96%
Dec 30, 2022156.80M41.01%
Dec 31, 2021111.20M4.41%
Dec 31, 2020106.50M367.11%
Dec 31, 201922.80M-37.36%
Dec 31, 201836.40M34.81%
Dec 29, 201727.00M-21.05%
Dec 30, 201634.20M33.59%
Dec 31, 201525.60M13.27%
Dec 31, 201422.60M-11.72%
Dec 31, 201325.60M26.73%
Dec 31, 201220.20M19.53%
Dec 30, 201116.90M-3.98%
Dec 31, 201017.60M-30.98%
Dec 31, 200925.50M-50.58%
Dec 31, 200851.60M-15.69%
Dec 31, 200761.20M-15.24%
Dec 29, 200672.20M-55.24%
Dec 30, 2005161.30M64.42%
Dec 31, 200498.10M-19.85%
Dec 31, 2003122.40M94.29%
Dec 31, 200263.00M156.10%
Dec 31, 200124.60M179.55%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company717.19B
Johnson & Johnson406.87B
AbbVie336.59B
Novo Nordisk309.02B
UnitedHealth Group265.35B
Novartis AG227.08B
AstraZeneca224.54B
Abbott Laboratories218.92B
Market Cap Rankings